Breast Cancer Physicians Have Limited Access to Trained Interpreters

Nov 11, 2009 By Valerie DeBenedette

In a new survey of physicians who treat breast cancer patients, only one-third said they had good access to trained medical interpreters or telephone language-interpretation systems when they needed it. Poor access to interpreters can compromise physician-patient communication that is critically important in cancer care.

The survey of 348 took place in the Los Angeles area, where 27 percent of residents — roughly 2.5 million people — have limited English proficiency (LEP) compared with 9 percent in the rest of the United States. Spanish and Asian languages are the predominant first languages for LEP in the LA region, but there are many others, said lead study author Danielle Rose, Ph.D.

Rose worked on the study while at the Cancer Prevention and Control Research in the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles. The study appears online in the journal Health Services Research.

Forty-two percent of respondents said they used a trained medical interpreter, 21 percent used a telephone interpreter service (where an interpreter is accessed by phone) and 75 percent reported using untrained interpreters, which could include bilingual office staff or the patient’s friends or family.

“Because of the wide diversity of the Los Angeles population, we were not surprised that many physicians used more than one interpreting option,” Rose said. Physicians at large medical facilities, such as HMOs or large hospitals, were more likely to have better access to trained interpreters or interpreter services.

One of the recommendations of the study is that Medicare reimburse for interpreter services, Rose said. “This way the doctors’ additional costs would be covered.”

The study stressed the importance of interpreters trained in dealing with medical issues.

“Somebody who speaks the language only is not enough. You have to have some medical background to understand the terminology, to explain to the patient what is happening,” said Georgeen Newland, project manager and health educator with Celebremos la Vida - Clinica Nuestra Salud of the Lombardi Center at Georgetown University Medical Center.

Although patients and physicians often use family or friends as interpreters, Rose warns of pitfalls. “There is a greater error rate with friends and family or other untrained interpreters,” she said, and there is risk of the family member advocating for one treatment over another or withholding information. Newland, who interprets for Spanish-speaking patients at Lombardi, concurred. “Sometimes the family does not tell the truth to protect the patient. I have witnessed that.”

More information: Rose DE, et al: Use of interpreters by physicians treating Limited English Proficient (LEP) women with breast cancer: results from the provider survey of the Los Angeles Women’s Health Study. Health Services Research online, 2009.

Provided by Health Behavior News Service (news : web)

Explore further: New drug sales help boost Novartis Q1 profit (Update)

add to favorites email to friend print save as pdf

Related Stories

Doctor: Patients need interpreters

Jul 21, 2006

A new study finds that millions of U.S. residents with limited English skills are at risk when they go to a hospital or a doctor's office.

Sign language interpreters at high ergonomic risk

Apr 17, 2008

Sign language interpreting is one of the highest-risk professions for ergonomic injury, according to a new study conducted by Rochester Institute of Technology. The research indicates that interpreting causes more physical ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.

Ocean microbes display remarkable genetic diversity

The smallest, most abundant marine microbe, Prochlorococcus, is a photosynthetic bacteria species essential to the marine ecosystem. An estimated billion billion billion of the single-cell creatures live i ...